Co-Authors
This is a "connection" page, showing publications co-authored by Kanta Subbarao and Kevin Selva.
Connection Strength
0.234
-
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay. JCI Insight. 2021 08 23; 6(16).
Score: 0.060
-
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2021 10; 21(10):1383-1394.
Score: 0.059
-
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat Commun. 2021 02 19; 12(1):1162.
Score: 0.058
-
Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19. Nat Commun. 2020 11 11; 11(1):5703.
Score: 0.057